202 related articles for article (PubMed ID: 29515033)
1. Calnexin is necessary for T cell transmigration into the central nervous system.
Jung J; Eggleton P; Robinson A; Wang J; Gutowski N; Holley J; Newcombe J; Dudek E; Paul AM; Zochodne D; Kraus A; Power C; Agellon LB; Michalak M
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515033
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K
J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735
[TBL] [Abstract][Full Text] [Related]
3. The Fabp5/calnexin complex is a prerequisite for sensitization of mice to experimental autoimmune encephalomyelitis.
Paskevicius T; Jung J; Pujol M; Eggleton P; Qin W; Robinson A; Gutowski N; Holley J; Smallwood M; Newcombe J; Zochodne D; Chen XZ; Tang J; Kraus A; Michalak M; Agellon LB
FASEB J; 2020 Dec; 34(12):16662-16675. PubMed ID: 33124722
[TBL] [Abstract][Full Text] [Related]
4. The Innate Immune Receptor CD14 Mediates Lymphocyte Migration in EAE.
Halmer R; Davies L; Liu Y; Fassbender K; Walter S
Cell Physiol Biochem; 2015; 37(1):269-75. PubMed ID: 26302995
[TBL] [Abstract][Full Text] [Related]
5. The blood-central nervous system barriers actively control immune cell entry into the central nervous system.
Engelhardt B
Curr Pharm Des; 2008; 14(16):1555-65. PubMed ID: 18673197
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
[TBL] [Abstract][Full Text] [Related]
7. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Elieh-Ali-Komi D; Cao Y
Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
[TBL] [Abstract][Full Text] [Related]
8. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
9. EGFL7 reduces CNS inflammation in mouse.
Larochelle C; Uphaus T; Broux B; Gowing E; Paterka M; Michel L; Dudvarski Stankovic N; Bicker F; Lemaître F; Prat A; Schmidt MHH; Zipp F
Nat Commun; 2018 Feb; 9(1):819. PubMed ID: 29483510
[TBL] [Abstract][Full Text] [Related]
10. PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier During Neuroinflammation.
Wimmer I; Tietz S; Nishihara H; Deutsch U; Sallusto F; Gosselet F; Lyck R; Muller WA; Lassmann H; Engelhardt B
Front Immunol; 2019; 10():711. PubMed ID: 31024547
[TBL] [Abstract][Full Text] [Related]
11. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
[TBL] [Abstract][Full Text] [Related]
12. Role of glucocorticoids on T cell recruitment across the blood-brain barrier.
Engelhardt B
Z Rheumatol; 2000; 59 Suppl 2():II/18-21. PubMed ID: 11155798
[TBL] [Abstract][Full Text] [Related]
13. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
14. Immune cell entry to central nervous system--current understanding and prospective therapeutic targets.
Prendergast CT; Anderton SM
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):315-27. PubMed ID: 20028334
[TBL] [Abstract][Full Text] [Related]
15. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
17. Regulation of immune cell entry into the central nervous system.
Engelhardt B
Results Probl Cell Differ; 2006; 43():259-80. PubMed ID: 17068976
[TBL] [Abstract][Full Text] [Related]
18. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
19. High Dimensional Cytometry of Central Nervous System Leukocytes During Neuroinflammation.
Mrdjen D; Hartmann FJ; Becher B
Methods Mol Biol; 2017; 1559():321-332. PubMed ID: 28063054
[TBL] [Abstract][Full Text] [Related]
20. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
